The effect of ferric citrate on IV iron, ESA utilization and laboratory parameters in real-world dialysis practice
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2017
Price : $35 *
At a glance
- Drugs Ferric citrate (Primary)
- Indications Hyperphosphataemia; Iron deficiency anaemia
- Focus Adverse reactions; Therapeutic Use
- 10 Nov 2017 New trial record
- 04 Nov 2017 According to a Keryx Biopharmaceuticals media release, data from this study were presented at the American Society of Nephrologys (ASN) 2017 Kidney Week.
- 04 Nov 2017 Results presented in a Keryx Biopharmaceuticals Media Release.